Lan Han

807 total citations
41 papers, 621 citations indexed

About

Lan Han is a scholar working on Molecular Biology, Complementary and alternative medicine and Neurology. According to data from OpenAlex, Lan Han has authored 41 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 11 papers in Complementary and alternative medicine and 10 papers in Neurology. Recurrent topics in Lan Han's work include Traditional Chinese Medicine Analysis (10 papers), Neuroinflammation and Neurodegeneration Mechanisms (8 papers) and Biological and pharmacological studies of plants (5 papers). Lan Han is often cited by papers focused on Traditional Chinese Medicine Analysis (10 papers), Neuroinflammation and Neurodegeneration Mechanisms (8 papers) and Biological and pharmacological studies of plants (5 papers). Lan Han collaborates with scholars based in China and United States. Lan Han's co-authors include Daiyin Peng, Can Peng, Xianchun Duan, Weidong Chen, Fan Xu, Zhuqing Liu, Yan Qi, Lianhong Yin, Mao Zhang and Lina Xu and has published in prestigious journals such as Journal of Ethnopharmacology, European Journal of Pharmacology and International Journal of Biological Macromolecules.

In The Last Decade

Lan Han

40 papers receiving 615 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lan Han China 16 294 118 97 78 69 41 621
Qiang Ye China 15 299 1.0× 101 0.9× 88 0.9× 73 0.9× 84 1.2× 49 916
Huafeng Pan China 14 313 1.1× 96 0.8× 89 0.9× 48 0.6× 94 1.4× 47 657
Shung‐Te Kao Taiwan 16 239 0.8× 103 0.9× 45 0.5× 93 1.2× 54 0.8× 30 609
Rongrong Li China 14 283 1.0× 72 0.6× 144 1.5× 53 0.7× 52 0.8× 37 728
Mihong Ren China 10 210 0.7× 64 0.5× 127 1.3× 61 0.8× 45 0.7× 22 456
Zhiyong Yan China 18 366 1.2× 129 1.1× 43 0.4× 78 1.0× 125 1.8× 76 802
Mei Ling Jin South Korea 12 297 1.0× 53 0.4× 63 0.6× 56 0.7× 70 1.0× 12 571

Countries citing papers authored by Lan Han

Since Specialization
Citations

This map shows the geographic impact of Lan Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Han more than expected).

Fields of papers citing papers by Lan Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lan Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Han. The network helps show where Lan Han may publish in the future.

Co-authorship network of co-authors of Lan Han

This figure shows the co-authorship network connecting the top 25 collaborators of Lan Han. A scholar is included among the top collaborators of Lan Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lan Han. Lan Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Lan, et al.. (2025). Inhibition of JAK2/STAT3 by pacritinib synergizes with chemotherapy in esophageal carcinoma. Toxicology in Vitro. 106. 106056–106056.
2.
Peng, Jinyong, et al.. (2024). Gastrodin against oxidative stress-inflammation crosstalk via inhibiting mtDNA/TLR9 and JAK2/STAT3 signaling to ameliorate ischemic stroke injury. International Immunopharmacology. 141. 113012–113012. 13 indexed citations
3.
Lin, Min, et al.. (2024). Atractylodes macrocephala polysaccharides shield a D-galactose-induced aging model via gut microbiota modulation. International Journal of Biological Macromolecules. 281(Pt 1). 136205–136205. 1 indexed citations
4.
Yu, Hao, Ning Wang, Xuerong Zhao, Lan Han, & Jinyong Peng. (2024). Integrated serum pharmacochemistry with network pharmacology and pharmacological validation to elucidate the mechanism of yiqitongmai decoction (YQTMD) against myocardial infarction. Journal of Ethnopharmacology. 331. 118329–118329. 3 indexed citations
5.
6.
Zhang, Mao, Xuerong Zhao, Lina Xu, et al.. (2023). Protective effects of dioscin against Parkinson's disease via regulating bile acid metabolism through remodeling gut microbiome/GLP-1 signaling. Journal of Pharmaceutical Analysis. 13(10). 1153–1167. 26 indexed citations
7.
Yin, Lianhong, et al.. (2023). Single-cell analysis of cellular heterogeneity and interactions in the ischemia-reperfusion injured mouse intestine. Journal of Pharmaceutical Analysis. 13(7). 760–775. 4 indexed citations
8.
Su, Xiaohui, Xueying Tao, Xia Mao, et al.. (2022). Anti-angiogenic effect of YuXueBi tablet in experimental rheumatoid arthritis by suppressing LOX/Ras/Raf-1 signaling. Journal of Ethnopharmacology. 298. 115611–115611. 13 indexed citations
9.
Wang, Ruirui, Lei Wang, Qing Liu, et al.. (2022). Exosomes as biomarkers and therapeutic measures for ischemic stroke. European Journal of Pharmacology. 939. 175477–175477. 5 indexed citations
10.
Liu, Qing, Weidong Chen, Ruirui Wang, et al.. (2022). Protection of Taohong Siwu Decoction on PC12 cells injured by oxygen glucose deprivation/reperfusion via mitophagy-NLRP3 inflammasome pathway in vitro. Journal of Ethnopharmacology. 301. 115784–115784. 24 indexed citations
11.
Jiang, Miaomiao, Hui Zhao, Lan Han, et al.. (2021). Synthesis of Paeonol-Ozagrel Conjugate: Structure Characterization and In Vivo Anti-Ischemic Stroke potential. Frontiers in Pharmacology. 11. 608221–608221. 11 indexed citations
12.
Ni, Wei‐Jian, et al.. (2021). Research Progress of Therapeutic Enzymes and Their Derivatives: Based on Herbal Medicinal Products in Rheumatoid Arthritis. Frontiers in Pharmacology. 12. 626342–626342. 7 indexed citations
13.
14.
Li, Lili, Qi Huang, Xianchun Duan, Lan Han, & Daiyin Peng. (2020). Protective effect of Clinopodium chinense (Benth.) O. Kuntze against abnormal uterine bleeding in female rats. Journal of Pharmacological Sciences. 143(1). 1–8. 14 indexed citations
15.
Wang, Mengmeng, Zhuqing Liu, Xianchun Duan, et al.. (2020). Taohong Siwu Decoction Ameliorates Ischemic Stroke Injury Via Suppressing Pyroptosis. Frontiers in Pharmacology. 11. 590453–590453. 63 indexed citations
16.
Chen, Fangfang, et al.. (2020). Tao-Hong-Si-Wu Decoction promotes angiogenesis after cerebral ischaemia in rats via platelet microparticles. Chinese Journal of Natural Medicines. 18(8). 620–627. 25 indexed citations
17.
Han, Lan, Weidong Chen, Jichen Wang, et al.. (2020). Uterine Metabolomics Reveals Protection of Taohong Siwu Decoction Against Abnormal Uterine Bleeding. Frontiers in Pharmacology. 11. 507113–507113. 15 indexed citations
18.
Duan, Xianchun, Lan Han, Daiyin Peng, et al.. (2019). High Throughput mRNA Sequencing Reveals Potential Therapeutic Targets of Tao-Hong-Si-Wu Decoction in Experimental Middle Cerebral Artery Occlusion. Frontiers in Pharmacology. 9. 1570–1570. 19 indexed citations
19.
Zhang, Yanyan, et al.. (2019). Deciphering the intervention mechanism of Taohong Siwu Decoction following the abnormal uterine bleeding rats based on serum metabolic profiles. Journal of Pharmaceutical and Biomedical Analysis. 170. 204–214. 18 indexed citations
20.
Yin, Dengke, Zhuqing Liu, Daiyin Peng, et al.. (2013). Serum Containing Tao-Hong-Si-Wu Decoction Induces Human Endothelial Cell VEGF Production via PI3K/Akt-eNOS Signaling. Evidence-based Complementary and Alternative Medicine. 2013. 1–9. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qiang Ye Breakdown of academic impact, for papers by Huafeng Pan Breakdown of academic impact, for papers by Shung‐Te Kao Breakdown of academic impact, for papers by Rongrong Li Breakdown of academic impact, for papers by Mihong Ren Breakdown of academic impact, for papers by Zhiyong Yan Breakdown of academic impact, for papers by Mei Ling Jin
Rankless by CCL
2026